BusinessSeeThruEquity Initiates Coverage on AXIM® Biotech (OTC: AXIM) With a Target Price of $17.0By Nasdaq OMXMay 16, 2017, 1:04 PM UTC
BusinessSeeThruEquity Initiates Coverage on AXIM® Biotech (OTC: AXIM) With a Target Price of $17.0By Nasdaq OMXMay 16, 2017, 1:04 PM UTC
BusinessSeeThruEquity Initiates Coverage on AXIM® Biotech (OTC: AXIM) With a Target Price of $17.0By Nasdaq OMXMay 16, 2017, 1:04 PM UTC
BusinessSeeThruEquity Initiates Coverage on AXIM® Biotech (OTC: AXIM) With a Target Price of $17.0By Nasdaq OMXMay 16, 2017, 1:04 PM UTC
BusinessCURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis IndustryBy Nasdaq OMXMay 10, 2017, 1:01 PM UTC
BusinessCURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis IndustryBy Nasdaq OMXMay 10, 2017, 1:01 PM UTC
BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
